Herantis Pharma Oyj: Manager's Transactions - Pekka Simula

Herantis Pharma Plc Company release 30 July 2018 at 9:30 am

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Pekka Simula

Position: Chief Executive Officer

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20180727055331_6

____________________________________________

Transaction date: 2018-06-13

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 320 Unit price: 6.85 EUR

Aggregated transactions

(1): Volume: 320 Volume weighted average price: 6.85 EUR

____________________________________________

Transaction date: 2018-06-15

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 150 Unit price: 6.85 EUR

Aggregated transactions

(1): Volume: 150 Volume weighted average price: 6.85 EUR

____________________________________________

Transaction date: 2018-06-19

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 253 Unit price: 6.85 EUR

Aggregated transactions

(1): Volume: 253 Volume weighted average price: 6.85 EUR

____________________________________________

Transaction date: 2018-07-27

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 293 Unit price: 7.3 EUR

(2): Volume: 10 Unit price: 7.4 EUR

Aggregated transactions

(2): Volume: 303 Volume weighted average price: 7.3033 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445 Company web site: www.herantis.com Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225

Distribution:

Nasdaq Helsinki Main media www.herantis.com